Description
The Head of Gynaecological Cancers, Senior Global Medical Affairs Leader turns therapy area strategy into scalable, high-quality execution across a sophisticated cluster of indications and assets. This role leads 5–6 Sr GMAL/GMALs who each own 1–2 indications, ensuring the ten core GMAL accountabilities are delivered consistently. The Global Medical Head sets direction, governs quality, and ensures compliant, efficient, and high-impact medical execution globally in support of an anticipated ~60 launches over three years across five tumor areas.
Ready to develop how evidence, insight, and strategy come together to redefine cancer care?
Provide indication and asset leadership by translating therapy area priorities into clear indication strategies, setting direction and making evidence-based trade-offs across the cluster to benefit global medical objectives, acting as final escalation point for sophisticated benefit-risk and reputational decisions.
Drive global medical strategy through cross-functional engagement by ensuring Sr GMAL/GMALs consistently lead key forums with markets, and by standardising operating cadences that align Development, Regulatory, Pharmacovigilance, Access, and non-promotional Commercial teams around the medical plan.
Lead all aspects of evidence generation governance by mentoring and approving indication evidence plans that address the most critical gaps, crafting strategy and develop of medical evidence (Phase IV, pragmatic studies, registries, RWE, IIS) and guiding operational support to deliver on time and on budget.
Share accountability for publications by partnering with Publications on cluster publication strategies, endorsing prioritisation, authorship plans and timelines, securing GPT/GPL endorsement, and ensuring scientific integrity and compliance with GPP/ICMJE.
Lead the cross-indication scientific narrative by ensuring Sr GMAL/GMALs lead coherent narratives and confidence-building strategies that are consistent across channels, geographies, and lifecycle stages.
Define medical education priorities at cluster level and provide subject-matter guidance so medical training and communications teams can design, develop, and deliver education aligned to the scientific platform.
Direct external engagement and partnerships strategy across indications, being responsible for execution with KEEs, societies, and appropriate partners in alignment with MESO on partnership frameworks and governance.
Lead congress strategy by defining the cross-indication congress plan, guiding symposia strategy, abstracts, booth scientific narratives, compliant engagements, and ensuring magnificent execution and robust post-congress insight collection.
Enable regions and integrate insights by sponsoring toolkits, core content, and training, establishing closed-loop insight systems so market feedback rapidly updates strategy, studies, and content.
Drive operational excellence by leading the cluster budget and vendor ecosystem, setting standards for medical planning, dashboards, risk and issue management, and MLR processes, while optimising FTE allocation across Sr GMAL/GMAL teams based on launch timing and complexity.
Lead risk, safety, and compliance by anticipating scientific and safety risks, partnering with Pharmacovigilance on signals, RMPs, and labeling updates, and upholding medical governance, promotional separation, and audit-ready documentation.
Act as an enterprise integrator by serving as senior medical counterpart to Development, Regulatory/Labeling, PV, HEOR/Market Access, Diagnostics/CDx, Digital, Manufacturing and regional medical leaders, aligning with MESO on partnerships and medical excellence standards.